annual operating expenses:
$441.29M+$5.76M(+1.32%)Summary
- As of today (May 24, 2025), FOLD annual total operating expenses is $441.29 million, with the most recent change of +$5.76 million (+1.32%) on December 31, 2024.
- During the last 3 years, FOLD annual operating expenses has fallen by -$29.68 million (-6.30%).
- FOLD annual operating expenses is now -10.86% below its all-time high of $495.06 million, reached on December 31, 2022.
Performance
FOLD Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$121.50M+$2.60M(+2.19%)Summary
- As of today (May 24, 2025), FOLD quarterly total operating expenses is $121.50 million, with the most recent change of +$2.60 million (+2.19%) on March 31, 2025.
- Over the past year, FOLD quarterly operating expenses has increased by +$2.99 million (+2.52%).
- FOLD quarterly operating expenses is now -29.01% below its all-time high of $171.17 million, reached on September 30, 2018.
Performance
FOLD quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FOLD Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | +2.5% |
| 3 y3 years | -6.3% | -13.8% |
| 5 y5 years | -4.3% | -7.3% |
FOLD Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.9% | +1.3% | -13.8% | +21.0% |
| 5 y | 5-year | -10.9% | +1.3% | -16.0% | +21.0% |
| alltime | all time | -10.9% | +6586.2% | -29.0% | +1087.5% |
FOLD Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $121.50M(+2.2%) |
| Dec 2024 | $441.29M(+1.3%) | $118.90M(+14.9%) |
| Sep 2024 | - | $103.44M(+3.0%) |
| Jun 2024 | - | $100.44M(-15.2%) |
| Mar 2024 | - | $118.51M(+10.3%) |
| Dec 2023 | $435.52M(-12.0%) | $107.45M(-1.0%) |
| Sep 2023 | - | $108.58M(+5.6%) |
| Jun 2023 | - | $102.78M(-11.9%) |
| Mar 2023 | - | $116.71M(-2.3%) |
| Dec 2022 | $495.06M(+5.1%) | $119.46M(+17.7%) |
| Sep 2022 | - | $101.53M(-23.7%) |
| Jun 2022 | - | $133.03M(-5.7%) |
| Mar 2022 | - | $141.04M(-2.5%) |
| Dec 2021 | $470.97M(-0.6%) | $144.72M(+35.3%) |
| Sep 2021 | - | $106.96M(+0.1%) |
| Jun 2021 | - | $106.85M(-5.0%) |
| Mar 2021 | - | $112.45M(-10.4%) |
| Dec 2020 | $473.70M(+2.8%) | $125.53M(+13.3%) |
| Sep 2020 | - | $110.77M(+4.2%) |
| Jun 2020 | - | $106.31M(-18.9%) |
| Mar 2020 | - | $131.10M(-4.1%) |
| Dec 2019 | $461.01M(+14.6%) | $136.73M(+37.2%) |
| Sep 2019 | - | $99.69M(-13.1%) |
| Jun 2019 | - | $114.71M(+4.4%) |
| Mar 2019 | - | $109.89M(+13.1%) |
| Dec 2018 | $402.32M(+66.5%) | $97.18M(-43.2%) |
| Sep 2018 | - | $171.17M(+164.1%) |
| Jun 2018 | - | $64.81M(-6.3%) |
| Mar 2018 | - | $69.16M(-8.4%) |
| Dec 2017 | $241.57M(+34.8%) | $75.50M(+19.6%) |
| Sep 2017 | - | $63.14M(+21.2%) |
| Jun 2017 | - | $52.11M(+2.5%) |
| Mar 2017 | - | $50.83M(+1.2%) |
| Dec 2016 | $179.19M(+42.2%) | $50.22M(-1.2%) |
| Sep 2016 | - | $50.82M(+32.5%) |
| Jun 2016 | - | $38.35M(-3.6%) |
| Mar 2016 | - | $39.80M(-1.5%) |
| Dec 2015 | $126.05M | $40.39M(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $36.74M(+42.0%) |
| Jun 2015 | - | $25.86M(+12.2%) |
| Mar 2015 | - | $23.05M(+7.3%) |
| Dec 2014 | $69.89M(+11.7%) | $21.49M(+21.4%) |
| Sep 2014 | - | $17.69M(+17.0%) |
| Jun 2014 | - | $15.13M(-2.9%) |
| Mar 2014 | - | $15.58M(+10.3%) |
| Dec 2013 | $62.56M(-12.3%) | $14.13M(-6.9%) |
| Sep 2013 | - | $15.17M(-5.2%) |
| Jun 2013 | - | $16.00M(-7.2%) |
| Mar 2013 | - | $17.25M(+8.3%) |
| Dec 2012 | $71.34M(-1.4%) | $15.92M(-5.9%) |
| Sep 2012 | - | $16.92M(-15.4%) |
| Jun 2012 | - | $19.98M(+7.9%) |
| Mar 2012 | - | $18.52M(-0.8%) |
| Dec 2011 | $72.32M(+27.4%) | $18.66M(-1.4%) |
| Sep 2011 | - | $18.93M(+0.9%) |
| Jun 2011 | - | $18.76M(+17.5%) |
| Mar 2011 | - | $15.96M(-8.6%) |
| Dec 2010 | $56.76M(-19.1%) | $17.46M(+31.6%) |
| Sep 2010 | - | $13.27M(+4.6%) |
| Jun 2010 | - | $12.69M(-5.0%) |
| Mar 2010 | - | $13.35M(-11.1%) |
| Dec 2009 | $70.19M(+19.1%) | $15.01M(-18.4%) |
| Sep 2009 | - | $18.39M(-4.3%) |
| Jun 2009 | - | $19.21M(+9.3%) |
| Mar 2009 | - | $17.57M(-8.6%) |
| Dec 2008 | $58.92M(+23.8%) | $19.22M(+48.4%) |
| Sep 2008 | - | $12.95M(-9.4%) |
| Jun 2008 | - | $14.30M(+14.9%) |
| Mar 2008 | - | $12.45M(-18.5%) |
| Dec 2007 | $47.59M(+1.6%) | $15.27M(+29.3%) |
| Sep 2007 | - | $11.81M(+14.8%) |
| Jun 2007 | - | $10.28M(+0.5%) |
| Mar 2007 | - | $10.23M |
| Dec 2006 | $46.86M(+124.9%) | - |
| Dec 2005 | $20.83M(+215.6%) | - |
| Dec 2003 | $6.60M | - |
FAQ
- What is Amicus Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Amicus Therapeutics?
- What is Amicus Therapeutics annual operating expenses year-on-year change?
- What is Amicus Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly operating expenses year-on-year change?
What is Amicus Therapeutics annual total operating expenses?
The current annual operating expenses of FOLD is $441.29M
What is the all time high annual operating expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total operating expenses is $495.06M
What is Amicus Therapeutics annual operating expenses year-on-year change?
Over the past year, FOLD annual total operating expenses has changed by +$5.76M (+1.32%)
What is Amicus Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of FOLD is $121.50M
What is the all time high quarterly operating expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total operating expenses is $171.17M
What is Amicus Therapeutics quarterly operating expenses year-on-year change?
Over the past year, FOLD quarterly total operating expenses has changed by +$2.99M (+2.52%)